In trading today, Eupraxia Pharmaceuticals Inc shares closed at $3.69 after opening the day at $3.78. prices ranged from a low of $3.44 to a high of $3.78.

Share prices advanced 2.50 percent from the previous day's close of $3.60.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21708.44, the S&P 500 closed sp_500_percentage_change% at 5022.21, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37753.31 and the Nasdaq Composite closed nasdaq_percentage_change% at 15683.37.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

Trading volume was 166,876 on 97 total trades, while having an average volume of 89,541 over 5 days.

Trading across the entire TSX saw 2,663 price advancers against 2,504 declines and 146 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.44 (April 18,2024). Moreover, the shares have shrunken -33.87% in 52 weeks, while this year, they have shrunken -31.28%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $128.24 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.17.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..